← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 21, 2016Last known activity
Aug 31, 2024
Timeline
1970s
- Jan 1, 1975
JCR Pharmaceuticals Co., Ltd.— Founded
2020s
- Mar 27, 2020
ArmaGen, Inc— Acquired
Drugs by trial phase (8 distinct, 18 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (3 own, 1 via acquisition)
Phase 1 (0 own, 1 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (13)
- NCT06488924Lead sponsorPhase 1/Phase 2Aug 31, 2024
- NCT06095388Lead sponsorPhase 1/Phase 2Oct 4, 2023
- NCT05594992Lead sponsorPhase 3Feb 1, 2023
- NCT04573023Lead sponsorPhase 3Nov 30, 2021
- NCT04453085Lead sponsorPhase 1/Phase 2May 1, 2021
- NCT04227600Lead sponsorPhase 1/Phase 2Sep 1, 2020
- NCT04348136Lead sponsorPhase 2/Phase 3Sep 1, 2019
- NCT03708965Lead sponsorPhase 2Jan 1, 2019
- NCT03568175Lead sponsorPhase 2/Phase 3Aug 1, 2018
- NCT03359213Lead sponsorPhase 2Jul 26, 2018
- NCT03128593Lead sponsorPhase 1/Phase 2Mar 30, 2017
- NCT02912494CollaboratorPhase 3Sep 21, 2016
- NCT02912533CollaboratorPhase 3Sep 21, 2016
Details
- Founded
- Ashiya, JP Jan 1, 1975
- Last known activity
- Aug 31, 2024